ORBi: Van Cutsem Eric - Clinical Activity and Benefit of Irinotecan (CPT-11) in Patients with Colorectal Cancer Truly Resistant to 5-Fluorouracil (5-FU)

Reference : Clinical Activity and Benefit of Irinotecan (CPT-11) in Patients with Colorectal Cancer ...


	Document type :	Scientific journals : Article
	Discipline(s) :	Human health sciences : Hematology
	To cite this reference:	http://hdl.handle.net/2268/12961

Title :	Clinical Activity and Benefit of Irinotecan (CPT-11) in Patients with Colorectal Cancer Truly Resistant to 5-Fluorouracil (5-FU)
Language :	English
Author, co-author :	Van Cutsem, Eric [ > > ]
	Cunningham, D. [ > > ]
	Ten Bokkel Huinink, W. W. [ > > ]
	Punt, C. J. A. [ > > ]
	Alexopoulos, C. G. [ > > ]
	Dirix, L. [ > > ]
	Symann, M. [ > > ]
	Blijham, G. H. [ > > ]
	Cholet, P. [ > > ]
	Fillet, Georges [Université de Liège - ULg > Département des sciences cliniques > Hématologie - Oncologie médicale >]
	Van Groeningen, C. [ > > ]
	Vannetzel, J. M. [ > > ]
	Levi, F. [ > > ]
	Panagos, G. [ > > ]
	Unger, C. [ > > ]
	Wils, J. [ > > ]
	Cote, C. [ > > ]
	Blanc, C. [ > > ]
	Hérait, P. [ > > ]
	Bleiberg, H. [ > > ]
Publication date :	1999
Journal title :	European Journal of Cancer
Publisher :	Elsevier Science
Volume :	35
Pages :	54-59
ISSN :	0959-8049
City :	Oxford
Country :	United Kingdom
Keywords :	[en] chemotherapy ; colon cancer ; CPT-11 ; 5-FU resistant ; irinotecan
Permalink :	http://hdl.handle.net/2268/12961

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Open access	145.pdf		Publisher postprint	89.04 kB	View/Open

All documents in ORBi are protected by a user license.